Could cord blood help treat long COVID?
While we have been focusing on the weather emergencies here in New Zealand, COVID-19 is still very much around and we are hearing constant reports about the debilitating condition known as long Covid.
Now, a Californian cord blood regenerative therapeutics company is about to enter phase two of clinical trials using umbilical cord blood stem cell therapy on Post-Covid Syndrome (PCS) patients. Symptoms of PCS include breathlessness, persistent cough, fatigue, pain, brain fog, anxiety, depression, palpitations, dizziness, weakness, and sleep problems. You can find out more about the trials here.